Search Legislation

The Human Medicines (Amendment) (No.3) Regulations 2015

What Version

 Help about what version
  • Latest available (Revised)
  • Original (As made)

Opening Options

 Help about opening options

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

Citation and commencement

1.  These Regulations may be cited as the Human Medicines (Amendment) (No.3) Regulations 2015 and shall come into force on 1st October 2015.

Amendment of the Human Medicines Regulations 2012

2.  The Human Medicines Regulations 2012(1) are amended as follows.

Amendment of regulation 8

3.—(1) Regulation 8(2) (general interpretation) is amended as follows.

(2) In paragraph (2), for “18(7) and (8)” substitute “18(4) and (5)”;

(3) In paragraph (3), for “18(8)” substitute “18(5)”; and

(4) In paragraph (4), for “18(8)” substitute “18(5)”.

Amendment of regulation 38

4.  In regulation 38 (imports from states other than EEA states), in paragraph (3)(b), for the words from “the principles” to the end substitute “good manufacturing practice for active substances”.

Amendment of regulation 39

5.  In regulation 39(3) (further requirements for manufacturer’s licence), in paragraph (8), for “44(4) to (6)” substitute “44(5) and (6)”.

Amendment of regulation 44

6.—(1) Regulation 44(4) (requirements for wholesale dealers to deal only with specified persons) is amended as follows.

(2) Omit paragraph (1).

(3) In paragraph(2)—

(a)for “From 28th October 2013 the” substitute “The”;

(b)after sub-paragraph (b), insert “or”;

(c)in sub-paragraph (c), for “country A; or” (at the end of the sub-paragraph) substitute “country A.”;

(d)omit sub-paragraph (d).

(4) In paragraph (3), omit “(1),”.

(5) Omit paragraph (4).

(6) In paragraph (5), for “From 28th October 2013, the” substitute “The”.

Amendment of regulation 233

7.—(1) Regulation 233(5) (exemption for supply etc under a PGD by person conducting a retail pharmacy business) is amended as follows.

(2) In paragraph (1)(a), after paragraph (ivc) insert—

(ivd)Public Health England,

(ive)Public Health Agency,.

(3) In paragraph (5), in sub-paragraph (a) for “to (ivc) (health bodies), on behalf of that body” substitute “to (ive) (health bodies), by or on behalf of the person specified in column 2 of Part 2 of Schedule 16 against the entry in column 1 for that body”.

Amendment of regulation 256E

8.  In regulation 256E(6) (removal of a person’s entry from the list), in paragraph (a), for “256I(1)(b)” substitute “256I(1)(c)”.

Amendment of regulation 346

9.—(1) Regulation 346(7) (Secretary of State to carry out a review of certain provisions) is amended as follows.

(2) In paragraph (2)—

(a)in sub-paragraph (c) after paragraph (xxviiif)(8) insert—

(xxviiifa)233(1)(a)(ivd) and (ive),;and

(b)in sub-paragraph (d), for paragraph (iva)(g) substitute—

(iva)17, Part 1 item 12, Part 2 items 4a and 11, Part 4 items 11 and 12 and Part 5 items 7a and 18,.

Amendment of Schedule 17

10.—(1) Schedule 17 (exemption for sale, supply or administration by certain persons) is amended as follows.

(2) In Part 2(9) (exemption from the restriction on supply of prescription only medicines), after item 4 in the table add—

4a Persons employed or engaged in the provision of drug treatment services provided by, on behalf of or under arrangements made by one of the following bodies-

(a) an NHS body;

(b) a local authority;

(c) Public Health England; or

(d) Public Health Agency

4a A prescription only medicine for parental administration containing naloxone hydrochloride but no other substance that is classified as a product available on prescription only.4a The supply shall be onl in the course of provisions of lawful drug treatment services and only where required for the purpose of saving life in an emergency.

(3) In Part 5(10) (exemptions from the restrictions in regulation 220 and 221 for certain persons who supply certain medicinal products), after item 7 in the table add—

7a Persons employed or engaged in the provision of drug treatment services provided by, on the behalf of or under arrangements made by one of the following bodies-

(a) an NHS body;

(b) a local authority;

(c) Public Health England; or

(d) Public Health Agency

7a A prescription only medicine for parental administration containing naloxone hydrochloride but no other substance that is classified as a product available on prescription only.7a The supply shall be only in the course of provisions of lawful drug treatment services and only where required for the purpose of saving life in an emergency.

Signed by the authority of the Secretary of State.

Jane Ellison

Parliamentary Under-Secretary of State,

Department of Health

9th July 2015

Simon Hamilton

Minister,

Department of Health, Social Services and Public Safety

9th July 2015

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made):The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources